Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2016-05-13 Merger & Acquisition
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and tender offers. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, indicating a merger or acquisition-related communication. The text is brief and appears to be a filing related to merger communications rather than a full report or announcement. Therefore, the document fits the category of Merger & Acquisition filings (MA).
2016-05-13 English
SC TO-I/A Filing
Merger & Acquisition Classification · 100% confidence The document is a Schedule TO filing with the SEC, specifically an Amendment No. 3 to a Tender Offer Statement under Rule 14d-100. It relates to a tender offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter common stock. The document includes detailed information about the tender offer, terms of the transaction, securities involved, and references to related prospectuses and registration statements. It also includes insider transactions and other regulatory disclosures related to the tender offer. This type of filing is specifically related to merger and acquisition activity, particularly tender offers, which falls under the category of Merger & Acquisition filings (MA). The document is not an earnings release, annual report, or other financial report, but a regulatory filing related to a takeover bid. Therefore, the correct classification is Merger & Acquisition (MA).
2016-05-12 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and tender offers. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, indicating a merger or acquisition context. The text is brief and appears to be a filing related to merger communications rather than a full report or announcement. Therefore, it fits the category of Merger & Acquisition filings.
2016-05-12 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Baxter International Inc. It reports on an event related to the annual meeting of stockholders held on May 3, 2016, specifically the approval of an amendment to the company's certificate of incorporation and subsequent legal proceedings. The document is short (3982 characters) and serves as a notification of a legal event and court hearing rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. The content fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories such as Annual Report, Earnings Release, or Legal Proceedings Report (LTR) since it is primarily a notice of a court hearing related to corporate governance matters rather than a lawsuit update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2016-05-11 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed pursuant to Rule 425 under the Securities Act of 1933, which relates to communications in connection with a merger or acquisition transaction. The text describes an exchange offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, including detailed terms of the offer, indicative exchange ratios, and references to a Prospectus. It also includes forward-looking statements and instructions on where to find the Prospectus and related SEC filings. The document is not a full financial report, earnings release, or management discussion, but rather a communication related to a merger/takeover offer. Rule 425 filings are typically merger communications. Therefore, the document fits best under the category of Merger & Acquisition (MA). The document length (8978 characters) and content confirm it is a substantive filing, not just an announcement or certification.
2016-05-11 English
PRIMARY DOCUMENT
Director's Dealing
2016-05-10 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.